Bevacizumab (Ingredient)

Drugbank ID: DB00112
ATC code: L01XC07

The information below refers to products available in the United States that contain bevacizumab.

Products containing bevacizumab

bevacizumab systemic

Brand names: Avastin, Mvasi, Zirabev, Vegzelma, Alymsys
Drug class: VEGF/VEGFR inhibitors

Bevacizumab systemic is used in the treatment of:

• Breast Cancer
• Breast Cancer, Metastatic
• Cervical Cancer
• Colorectal Cancer
• Fallopian Tube Cancer
• Glioblastoma Multiforme
• Hepatocellular Carcinoma
• Macular Degeneration
• Malignant Glioma
• Neurofibromatosis
• Non Small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Peritoneal Cancer
• Renal Cell Carcinoma
• Solid Tumors

bevacizumab ophthalmic

Drug class: anti-angiogenic ophthalmic agents

Bevacizumab ophthalmic is used in the treatment of:

• Macular Degeneration

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer